Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,548,802
-$145,937 QoQ
Shares Held
12,259
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#913
of 2,266 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gould Capital, LLC holds $5,361,370 across 4 Drug Manufacturers - General names. GILD ranks #2 (28.9% of the industry book) .
All Filings in GILD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,548,802 | 12,259 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,694,739 | 12,160 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,642,997 | 13,386 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,493,838 | 13,458 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,477,564 | 13,327 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,520,630 | 13,571 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,449,931 | 15,697 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $1,352,171 | 16,128 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $905,720 | 13,201 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $911,596 | 12,445 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $862,189 | 10,643 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $875,149 | 11,678 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $837,057 | 10,861 | Shares | Sole | 2023-08-25 | |
| 2023-03-31 | $12,528 | 151 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $8,585 | 100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,711 | 125 | Shares | Sole | 2022-11-23 | |
| No filing history on record for this holder in this stock. | ||||||